Geode Capital Management’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$431K Sell
706,334
-64,369
-8% -$39.3K ﹤0.01% 3600
2025
Q1
$582K Buy
770,703
+3,162
+0.4% +$2.39K ﹤0.01% 3491
2024
Q4
$739K Sell
767,541
-1,025
-0.1% -$986 ﹤0.01% 3473
2024
Q3
$1.11M Buy
768,566
+97,567
+15% +$141K ﹤0.01% 3318
2024
Q2
$812K Sell
670,999
-533,962
-44% -$646K ﹤0.01% 3389
2024
Q1
$2.83M Buy
1,204,961
+543,166
+82% +$1.28M ﹤0.01% 2974
2023
Q4
$1.25M Buy
661,795
+28,841
+5% +$54.5K ﹤0.01% 3263
2023
Q3
$867K Sell
632,954
-15
-0% -$21 ﹤0.01% 3386
2023
Q2
$1.54M Buy
632,969
+26,780
+4% +$65.1K ﹤0.01% 3196
2023
Q1
$3.49M Buy
606,189
+16,033
+3% +$92.4K ﹤0.01% 2793
2022
Q4
$5.28M Buy
590,156
+51,661
+10% +$462K ﹤0.01% 2636
2022
Q3
$7.66M Buy
538,495
+116,927
+28% +$1.66M ﹤0.01% 2433
2022
Q2
$6.15M Buy
421,568
+29,733
+8% +$434K ﹤0.01% 2584
2022
Q1
$7.82M Buy
391,835
+83,314
+27% +$1.66M ﹤0.01% 2508
2021
Q4
$5.4M Sell
308,521
-30,839
-9% -$539K ﹤0.01% 2855
2021
Q3
$2.66M Buy
339,360
+21,019
+7% +$165K ﹤0.01% 3234
2021
Q2
$3.28M Buy
318,341
+199,026
+167% +$2.05M ﹤0.01% 3119
2021
Q1
$1.56M Buy
119,315
+85,839
+256% +$1.12M ﹤0.01% 3375
2020
Q4
$470K Buy
33,476
+4,655
+16% +$65.4K ﹤0.01% 3609
2020
Q3
$342K Sell
28,821
-638
-2% -$7.57K ﹤0.01% 3555
2020
Q2
$443K Sell
29,459
-20,247
-41% -$304K ﹤0.01% 3416
2020
Q1
$358K Buy
49,706
+2,058
+4% +$14.8K ﹤0.01% 3363
2019
Q4
$496K Buy
47,648
+17,222
+57% +$179K ﹤0.01% 3505
2019
Q3
$1.88M Buy
30,426
+2,002
+7% +$124K ﹤0.01% 2973
2019
Q2
$2.03M Buy
28,424
+15,516
+120% +$1.11M ﹤0.01% 2942
2019
Q1
$616K Buy
12,908
+559
+5% +$26.7K ﹤0.01% 3349
2018
Q4
$745K Buy
12,349
+2,216
+22% +$134K ﹤0.01% 3229
2018
Q3
$1.07M Buy
10,133
+801
+9% +$84.8K ﹤0.01% 3193
2018
Q2
$597K Buy
9,332
+1,387
+17% +$88.7K ﹤0.01% 3376
2018
Q1
$532K Buy
+7,945
New +$532K ﹤0.01% 3373